Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001733476 | SCV001983900 | uncertain significance | not provided | 2021-04-22 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function |
Ambry Genetics | RCV002361010 | SCV002625493 | uncertain significance | Cardiovascular phenotype | 2024-08-19 | criteria provided, single submitter | clinical testing | The p.V1272M variant (also known as c.3814G>A), located in coding exon 9 of the TNXB gene, results from a G to A substitution at nucleotide position 3814. The valine at codon 1272 is replaced by methionine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Zotz- |
RCV003333769 | SCV004041645 | uncertain significance | Ehlers-Danlos syndrome due to tenascin-X deficiency | 2023-10-09 | no assertion criteria provided | clinical testing |